{
    "nctId": "NCT02332291",
    "officialTitle": "Connectivity Affecting the Antidepressant REsponse (The CAARE Study)",
    "inclusionCriteria": "1. Age 60 years or older.\n2. Current diagnosis of major depressive disorder (DSM-IV-TR), single episode, recurrent or chronic, without psychotic features, as detected by Mini-International Neuropsychiatric Inventory (MINI) and clinical exam.\n3. Minimum MADRS score \u2265 15.\n4. Mini-Mental State Exam \u2265 24.\n5. Fluent in English.\n* Must have minimum age of 60 Years",
    "exclusionCriteria": "1. Current or past diagnoses of other Axis I psychiatric disorders, except for generalized anxiety disorder (GAD) symptoms occurring during a depressive episode\n2. History of alcohol or drug dependence or abuse in the last three years\n3. History of developmental disorder or Intelligence Quotient score \\< 70\n4. Presence of acute suicidality\n5. Acute grief (\\< 1 month)\n6. Current or past psychosis\n7. Primary neurological disorder, including but not limited to dementia, stroke, brain tumors, epilepsy, Parkinson's disease, or demyelinating diseases\n8. MRI contraindications\n9. Any physical or intellectual disability adversely affecting ability to complete assessments\n10. Electroconvulsive therapy in last 6 months\n11. Use of antidepressant medications or other psychotropic medications in the last 4 weeks (or the last 6 weeks for fluoxetine). Occasional use of benzodiazepines or non-benzodiazepine sedatives (such as zolpidem, eszopiclone, or zaleplon) during this period is allowable.\n12. A failed therapeutic trial of escitalopram in the current depressive episode (defined as at least 6 weeks of treatment at a daily dose of 10mg or higher)\n13. Known allergy or hypersensitivity to escitalopram or bupropion\n14. Current or planned psychotherapy"
}